Table 8.6i

Immunosuppression Use for Antirejection Treatment from Transplant

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		972	941	915	891	905	871	881	903	924	862
Tx with Antirejection Treatments		286	260	232	194	191	153	127	118	107	93
Antibodies	Any in Category	44.4%	42.3%	41.4%	32.0%	50.8%	58.2%	63.0%	50.8%	49.5%	51.6%
	Atgam/NRATG/NRATS	10.1%	6.5%	3.9%	0.5%	2.6%	2.0%	3.1%	2.5%	2.8%	0.0%
	OKT3	35.7%	24.6%	22.8%	12.4%	10.5%	9.8%	11.8%	11.0%	6.5%	9.7%
	Thymoglobulin	3.1%	16.2%	15.1%	20.6%	34.0%	39.9%	44.1%	39.0%	34.6%	37.6%
	Zenapax	1.7%	1.5%	1.7%	1.0%	4.7%	11.8%	7.1%	7.6%	9.3%	9.7%
	Simulect	0.0%	0.4%	2.2%	0.5%	1.0%	1.3%	1.6%	0.0%	0.9%	0.0%
	Campath	0.0%	0.0%	0.0%	0.0%	0.5%	3.9%	2.4%	0.0%	0.0%	2.2%
Corticosteroids	Any in Category	77.6%	80.8%	82.8%	87.1%	76.4%	68.6%	68.5%	71.2%	68.2%	67.7%
Corticosteroids	Steroids	77.6%	80.8%	82.8%	87.1%	76.4%	68.6%	68.5%	71.2%	68.2%	67.7%
Antimetabolites	Any in Category	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.9%	0.0%
	Cytoxan	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Methotrexate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.9%	0.0%